OBJECTIVE: The aim of this study was to compare quality of care and outcomes between Veteran and non-Veteran patients undergoing surgery for clinical stage I non-small cell lung cancer (NSCLC). BACKGROUND: Prior studies and the lay media have questioned the quality of care that Veterans with lung cancer receive through the Veterans Health Administration (VHA). We hypothesized Veterans undergoing surgery for early-stage NSCLC receive high quality care and have similar outcomes compared to the general population. METHODS: We performed a retrospective cohort study of patients with clinical stage I NSCLC undergoing resection from 2006 to 2016 using a VHA dataset. Propensity score matching for baseline patient- and tumor-related variables was used to compare operative characteristics and outcomes between the VHA and the National Cancer Database (NCDB). RESULTS: The unmatched cohorts included 9,981 VHA and 176,304 NCDB patients. The VHA had more male, non-white patients with lower education levels, higher incomes, and higher Charlson/Deyo scores. VHA patients had inferior unadjusted 30-day mortality (VHA 2.1% vs NCDB 1.7%, p = 0.011) and median overall survival (69.0 vs 88.7 months, p < 0.001). In the propensity matched cohort of 6,792 pairs, VHA patients were more likely to have minimally invasive operations (60.0% vs 39.6%, p < 0.001) and only slightly less likely to receive lobectomies (70.1% vs 70.7%, p = 0.023). VHA patients had longer lengths of stay (8.1 vs 7.1 days, p < 0.001) but similar readmission rates (7.7% vs 7.0%, p = 0.132). VHA patients had significantly better 30-day mortality (1.9% vs 2.8%, p < 0.001) and median overall survival (71.4 vs 65.2 months, p < 0.001). CONCLUSIONS: Despite having more comorbidities, Veterans receive exceptional care through the VHA with favorable outcomes, including significantly longer overall survival, compared to the general population. Copyright (C) 2021 Wolters Kluwer Health, Inc. All rights reserved.
OBJECTIVE: The aim of this study was to compare quality of care and outcomes between Veteran and non-Veteran patients undergoing surgery for clinical stage I non-small cell lung cancer (NSCLC). BACKGROUND: Prior studies and the lay media have questioned the quality of care that Veterans with lung cancer receive through the Veterans Health Administration (VHA). We hypothesized Veterans undergoing surgery for early-stage NSCLC receive high quality care and have similar outcomes compared to the general population. METHODS: We performed a retrospective cohort study of patients with clinical stage I NSCLC undergoing resection from 2006 to 2016 using a VHA dataset. Propensity score matching for baseline patient- and tumor-related variables was used to compare operative characteristics and outcomes between the VHA and the National Cancer Database (NCDB). RESULTS: The unmatched cohorts included 9,981 VHA and 176,304 NCDB patients. The VHA had more male, non-white patients with lower education levels, higher incomes, and higher Charlson/Deyo scores. VHA patients had inferior unadjusted 30-day mortality (VHA 2.1% vs NCDB 1.7%, p = 0.011) and median overall survival (69.0 vs 88.7 months, p < 0.001). In the propensity matched cohort of 6,792 pairs, VHA patients were more likely to have minimally invasive operations (60.0% vs 39.6%, p < 0.001) and only slightly less likely to receive lobectomies (70.1% vs 70.7%, p = 0.023). VHA patients had longer lengths of stay (8.1 vs 7.1 days, p < 0.001) but similar readmission rates (7.7% vs 7.0%, p = 0.132). VHA patients had significantly better 30-day mortality (1.9% vs 2.8%, p < 0.001) and median overall survival (71.4 vs 65.2 months, p < 0.001). CONCLUSIONS: Despite having more comorbidities, Veterans receive exceptional care through the VHA with favorable outcomes, including significantly longer overall survival, compared to the general population. Copyright (C) 2021 Wolters Kluwer Health, Inc. All rights reserved.
Authors: Mary Beth Landrum; Nancy L Keating; Elizabeth B Lamont; Samuel R Bozeman; Barbara J McNeil Journal: Cancer Date: 2011-11-09 Impact factor: 6.860
Authors: Leah L Zullig; Kellie J Sims; Rebecca McNeil; Christina D Williams; George L Jackson; Dawn Provenzale; Michael J Kelley Journal: Mil Med Date: 2017-07 Impact factor: 1.437
Authors: Leah L Zullig; Valerie A Smith; George L Jackson; Susanne Danus; Merritt Schnell; Jennifer Lindquist; Dawn Provenzale; Morris Weinberger; Michael J Kelley; Hayden B Bosworth Journal: Clin Colorectal Cancer Date: 2016-05-07 Impact factor: 4.481
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: Karl Y Bilimoria; Clifford Y Ko; James S Tomlinson; Andrew K Stewart; Mark S Talamonti; Denise L Hynes; David P Winchester; David J Bentrem Journal: Ann Surg Date: 2011-04 Impact factor: 12.969
Authors: Brendan T Heiden; Daniel B Eaton; Su-Hsin Chang; Yan Yan; Martin W Schoen; Li-Shiun Chen; Nina Smock; Mayank R Patel; Daniel Kreisel; Ruben G Nava; Bryan F Meyers; Benjamin D Kozower; Varun Puri Journal: Chest Date: 2021-12-14 Impact factor: 10.262
Authors: Brendan T Heiden; Daniel B Eaton; Su-Hsin Chang; Yan Yan; Martin W Schoen; Li-Shiun Chen; Nina Smock; Mayank R Patel; Daniel Kreisel; Ruben G Nava; Bryan F Meyers; Benjamin D Kozower; Varun Puri Journal: Ann Surg Date: 2021-11-18 Impact factor: 13.787